BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 19022928)

  • 1. Coagulation and fibrosis in chronic liver disease.
    Calvaruso V; Maimone S; Gatt A; Tuddenham E; Thursz M; Pinzani M; Burroughs AK
    Gut; 2008 Dec; 57(12):1722-7. PubMed ID: 19022928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin and protease-activated receptors (PARs) in atherothrombosis.
    Martorell L; Martínez-González J; Rodríguez C; Gentile M; Calvayrac O; Badimon L
    Thromb Haemost; 2008 Feb; 99(2):305-15. PubMed ID: 18278179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation.
    Fiorucci S; Antonelli E; Distrutti E; Severino B; Fiorentina R; Baldoni M; Caliendo G; Santagada V; Morelli A; Cirino G
    Hepatology; 2004 Feb; 39(2):365-75. PubMed ID: 14767989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivo.
    De Minicis S; Candelaresi C; Marzioni M; Saccomano S; Roskams T; Casini A; Risaliti A; Salzano R; Cautero N; di Francesco F; Benedetti A; Svegliati-Baroni G
    Gut; 2008 Mar; 57(3):352-64. PubMed ID: 17989109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury.
    Marra F; DeFranco R; Grappone C; Milani S; Pinzani M; Pellegrini G; Laffi G; Gentilini P
    Hepatology; 1998 Feb; 27(2):462-71. PubMed ID: 9462645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronological expression of PAR isoforms in acute liver injury and its amelioration by PAR2 blockade in a rat model of sepsis.
    Jesmin S; Gando S; Zaedi S; Sakuraya F
    Thromb Haemost; 2006 Dec; 96(6):830-8. PubMed ID: 17139380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C.
    Carotti S; Morini S; Corradini SG; Burza MA; Molinaro A; Carpino G; Merli M; De Santis A; Muda AO; Rossi M; Attili AF; Gaudio E
    Liver Transpl; 2008 Jun; 14(6):806-14. PubMed ID: 18508359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin receptors in vascular smooth muscle cells - function and regulation by vasodilatory prostaglandins.
    Schrör K; Bretschneider E; Fischer K; Fischer JW; Pape R; Rauch BH; Rosenkranz AC; Weber AA
    Thromb Haemost; 2010 May; 103(5):884-90. PubMed ID: 20143010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
    Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
    Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverse association between hepatic stellate cell apoptosis and fibrosis in chronic hepatitis C virus infection.
    Gonzalez SA; Fiel MI; Sauk J; Canchis PW; Liu RC; Chiriboga L; Yee HT; Jacobson IM; Talal AH
    J Viral Hepat; 2009 Feb; 16(2):141-8. PubMed ID: 19175868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GFAP expression in the liver as an early marker of stellate cells activation.
    Morini S; Carotti S; Carpino G; Franchitto A; Corradini SG; Merli M; Gaudio E
    Ital J Anat Embryol; 2005; 110(4):193-207. PubMed ID: 16536051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of insulin resistance on the progression of chronic liver diseases.
    Kaji K; Yoshiji H; Kitade M; Ikenaka Y; Noguchi R; Yoshii J; Yanase K; Namisaki T; Yamazaki M; Moriya K; Tsujimoto T; Kawaratani H; Akahane T; Uemura M; Fukui H
    Int J Mol Med; 2008 Dec; 22(6):801-8. PubMed ID: 19020779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation cascade proteases and tissue fibrosis.
    Chambers RC; Laurent GJ
    Biochem Soc Trans; 2002 Apr; 30(2):194-200. PubMed ID: 12023850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relaxin receptors in hepatic stellate cells and cirrhotic liver.
    Bennett RG; Dalton SR; Mahan KJ; Gentry-Nielsen MJ; Hamel FG; Tuma DJ
    Biochem Pharmacol; 2007 Apr; 73(7):1033-40. PubMed ID: 17214975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relaxin receptor expression in hepatic stellate cells and in cirrhotic rat liver tissue.
    Bennett RG; Mahan KJ; Gentry-Nielsen MJ; Tuma DJ
    Ann N Y Acad Sci; 2005 May; 1041():185-9. PubMed ID: 15956705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease-activated receptors in the musculoskeletal system.
    Mackie EJ; Loh LH; Sivagurunathan S; Uaesoontrachoon K; Yoo HJ; Wong D; Georgy SR; Pagel CN
    Int J Biochem Cell Biol; 2008; 40(6-7):1169-84. PubMed ID: 18243039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous alpha-calcitonin gene-related peptide mitigates liver fibrosis in chronic hepatitis induced by repeated administration of concanavalin A.
    Kamiyoshi A; Sakurai T; Ichikawa-Shindo Y; Iinuma N; Kawate H; Yoshizawa T; Koyama T; Muto S; Shindo T
    Liver Int; 2009 May; 29(5):642-9. PubMed ID: 18673438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin signaling in the brain: the role of protease-activated receptors.
    Wang H; Reiser G
    Biol Chem; 2003 Feb; 384(2):193-202. PubMed ID: 12675511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Migration of hepatic stellate cells in fibrotic microenvironment of diseased liver model.
    Chang YZ; Yang L; Yang CQ
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):401-5. PubMed ID: 18693176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease-activated receptors in vascular biology.
    Coughlin SR
    Thromb Haemost; 2001 Jul; 86(1):298-307. PubMed ID: 11487018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.